相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer
S. B. Campbell et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial
Josefina Alberu et al.
TRANSPLANTATION (2011)
Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study
Ulrich Frei et al.
CLINICAL TRANSPLANTATION (2010)
Immune Phenotype Predicts Risk for Posttransplantation Squamous Cell Carcinoma
Robert P. Carroll et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Conversion From Calcineurin Inhibitors to Sirolimus Maintenance Therapy in Renal Allograft Recipients: 24-Month Efficacy and Safety Results From the CONVERT Trial
Francesco P. Schena et al.
TRANSPLANTATION (2009)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Jan P. Vandenbroucke et al.
ANNALS OF INTERNAL MEDICINE (2007)
Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors
D. San Segundo et al.
TRANSPLANTATION PROCEEDINGS (2007)
Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients
David San Segundo et al.
TRANSPLANTATION (2006)
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
Josep M. Campistol et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: Influence of anti-T-cell antibodies and association with posttransplant malignancies
D Thibaudin et al.
TRANSPLANTATION (2005)
Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin in human on the induction of FOXP3 T cells
CC Baan et al.
TRANSPLANTATION (2005)
The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation
I Beuvink et al.
CELL (2005)
Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies
T Mathew et al.
CLINICAL TRANSPLANTATION (2004)
Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation
M Guba et al.
TRANSPLANTATION (2004)
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice
GE Koehl et al.
TRANSPLANTATION (2004)
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
M Guba et al.
NATURE MEDICINE (2002)
分享论文
